Axogen, Inc. — Director's Dealing 2017

Sep 12, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2017-09-08

Reporting Person: Rudelius Robert James (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-09-08	Common Stock	M	20000	$3.50	Acquired	43273	Direct
2017-09-08	Common Stock	F	3857	$18.15	Disposed	39416	Direct
2017-09-11	Common Stock	S	16143	$18.00	Disposed	23273	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-09-08	Director Stock Option (right to purchase)	$3.50	M	20000	Disposed	2017-11-01	Common Stock (20000)	Direct

Footnotes

F1: This Form is being filed to report the exercise of a stock option for a total of 20,000 shares by means of a cashless exercise. A cashless exercise is a method of exercising a stock option in which the option holder pays the exercise price using shares the reporting person would have received pursuant to the option exercise. As a result of this cashless exercise, the Reporting Person, on a net basis, acquired ownership of an additional 16,143 shares of common stock.

F2: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2017.